by
sterling1
on
Mar 11, 2010 • Comments Closed
This is an important update to the Food and Drug Administration’s (FDA) timelines for UDI (Unique Device Identification) implementation deadlines. It comes by way of a recently published article entitled, “The FDA’s Take on Unique Device Identification,” authored by Jay Crowley who is senior advisor for patient safety for the Food and Drug Administration’s Center for Devices...
by
sterling1
on
Mar 9, 2010 • Comments Closed
We have a brand new and very compelling White Paper just out. Compliance with UDI Labeling Mandates: A Proven Methodology, was produced because, as the introduction states: There has never been a better or more urgent time for manufacturers of healthcare products to make a close examination of their product labeling systems. If you read...
GS1 Healthcare US has posted a new success story,
This morning, The Financial Express is running a front page story entitled ‘Generics Gateway ,’ by BV Mahalakshmi and Sudhir Chowdhary. While it is primarily interested in pumping up India’s emerging role in helping global pharmaceutical companies source new products, exploit new generics opportunities and secure lower-cost operations all in India, there is a much bigger story to be found...
I go to the U.S. Food and Drug Administration (FDA) website almost every day to glimpse their recent news releases. That’s because sometimes their announcements don’t seem to get much pick up in the usual places. Yesterday they issued this news release. The headline is: FDA Unveils Safe Use Initiative that Targets Preventable Harm from Medication...
In this article, entitled “Major pharmaceutical companies see generics as a bridge to the future,” writer Clay Boswell first provides a review of all the major acquisitions, mergers and joint marketing agreements by large pharmaceutical companies over the past couple of years.
Uncategorized
If you’re not familiar with the American Society of Health-System Pharmacists (ASHP) — and especially if you are a pharmacist — you may want to check them out.
Okay, we continue to see bad actors in the supply chain and they continue to be . . .
by
sterling1
on
Jul 29, 2009 • Comments Closed
Sanofi, the major pharmaceutical company based in France, has purchased a controlling interest in Shantha Biotechnics, a vaccines company based in India.
by
sterling1
on
Jul 22, 2009 • Comments Closed
We’ve covered this topic earlier but today’s news is that pilot organizers and participants have published their findings, recommendations and conclusions in the project’s Evaluation Report. The news release about this is here. A link to the complete recommendations document is here. The bottom line is: The project team found that full supply chain traceability systems...
For your convenience in keeping up with some of the things that made news at the recent Global GS1 Healthcare Conference
Uncategorized
by
sterling1
on
Jun 15, 2009 • Comments Closed
Everybody has their reasons for embracing, or shunning, an emerging market strategy. But if you want to know what ‘the world’s leading drug maker’ is thinking about emerging markets, and their reasons for thinking it, you’ll check out this very brief bulletin today in FinancierWorldwide featuring Jean-Michel Halfon, who runs Pfizer’s emerging market unit.